Ozempic And Wegovy Can Help Smokers Quit, Study Suggests
Topline
Novo Nordisk’s weight-loss and diabetes drug semaglutide—a drug called Wegovy and Ozempic—could help people quit smoking, new research published Monday suggests, adding in evidence that popular drugs can also help treat alcoholism as companies see new markets during growth. It is reported that GLP-1 drugs can be used in a variety of different conditions such as heart disease, dementia and sleep apnea.
Ozempic can help people quit smoking, researchers said.
Important Points
Smokers with type 2 diabetes who used semaglutide were less likely to need medical care related to tobacco use than those who used other diabetes drugs, according to a study is peer-published in the Annals of Internal Medicine.
Researchers from Case Western Reserve University in Ohio and the National Center on Drug Abuse investigated the effect of semaglutide on tobacco addiction compared to seven other diabetes medications by analyzing data from health records. the US electronic beauty of about 223,000 people who started using drugs between 2017 and early 2023. .
Semaglutide was associated with a “very low risk for clinical contact” for care related to tobacco addiction, formally defined as “tobacco use disorder” (TUD), the researchers said.
When comparing patients using drugs such as insulin, metformin and other drugs in the same GLP-1 class as semaglutide, and reporting factors such as age, sex and other health conditions, the researchers found that patients using Ozempic were less likely to be diagnosed with diabetes. TUD, along with less chance of receiving smoking cessation counseling or medication that will help them quit smoking.
The studies do not clearly show that people taking semaglutide are successful in quitting smoking—semaglutide users may not seek medical attention or help to quit smoking, for example—but researchers say the reduction while the maintenance of TUD and related. health reports have shown that semaglutide users have successfully quit.
As an observational study, there is also no evidence that iron-containing semaglutide was responsible for the apparent reduction in smoking seen and the researchers said their findings should be followed up with more robust clinical trials. to investigate whether Ozempic and Wegovy can be used to help people. quit smoking.
How Can Glp-1 Drugs Like Ozempic and Wegovy Help Treat Alcoholism?
There is no clear evidence that GLP-1 drugs like semaglutide can help treat addiction. But there have been increasing reports that it has helped people to curb bad behavior such as drinking, smoking tobacco, marijuana, other drugs such as cocaine, skin picking, gambling and even and shopping and nail biting. Both Novo Nordisk and Eli Lilly—which makes diabetes and weight-loss blockbusters Mounjaro and Zepbound (brand names for tirzepatide)—are actively exploring potential properties. be an anti-addiction drug, which mimics the gut hormone involved in controlling hunger and blood sugar. It is not clear why GLP-1s appear to reduce obesity, or have even been proven to do so, and their full mechanism for weight loss is not fully understood. The drugs appear to cause weight loss by delaying ovulation, making people feel fuller for longer, and also reducing appetite. Researchers hypothesize that by targeting the areas of the brain involved in controlling appetite they can also target other pathways of desire, pathways that are often hijacked by addictive substances or behaviors and play a major role in addiction.
Big Number
480,000. That’s how many people die from cigarette smoking each year in the US, according to the CDC, nearly one in five deaths.
A surprising fact
More than 10 times more US citizens have died prematurely from smoking than have died in all the wars the US has fought, the CDC says.
Continue Reading
Get Forbes Breaking News Text Alerts: We’re introducing text message alerts so you can stay up-to-date on the biggest stories of the day. Text “Alerts” at (201) 335-0739 or sign up Here.
#Ozempic #Wegovy #Smokers #Quit #Study #Suggests